Skip to content
healthcare.dev

Atracurium Besylate

NDC 55150-216, Atracurium Besylate, injection, solution, from AuroMedics Pharma LLC.

Product NDC
55150-216
Status
Listed
Labeler
AuroMedics Pharma LLC
Dosage form
INJECTION, SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA206010
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/55150-216 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ATRACURIUM BESYLATE50 mg/5mL

Pharmacologic classes

Neuromuscular Nondepolarizing Blockade [PE]; Nondepolarizing Neuromuscular Blocker [EPC]

Package NDCNDC-11Package
55150-216-055515002160510 VIAL, SINGLE-USE in 1 CARTON (55150-216-05) / 5 mL in 1 VIAL, SINGLE-USE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/71d4bc78-57df-474b-8b19-811a959f1fce

Use it

Look up 55150-216 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/55150-216 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 55150-216. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.